FDA Inspection 1084148 — Oklahoma Blood Institute Norman Center
The FDA completed an inspection of Oklahoma Blood Institute Norman Center on March 22, 2019 in Norman, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 22, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Norman, OK (United States)